In a Friday morning phone interview Boulware said, “I would not give him magic beans, so I would not give him hydroxychloroquine, “This is not going to be an effective therapy.”
A research at the University of Minnesota revealed that it is not effective in treating the condition of those that are suffering from early and mild symptoms of the virus. Hydroxychloroquine is usually taken to treat symptoms of lupus, malaria and arthritis.
Donald Trump, on the other hand, has regarded its ability as a saver against the virus. Though several studies have revealed that it does not help fight the virus, several hydroxychloroquine supporters continue to regard it as a potential treatment and use it early on in the course of infection.
“There’s no data that there’s a substantial, clinically meaningful benefit for hydroxychloroquine as early therapy”, Boulware said.
According to the study published by the University of Minnesota study, it does not have any treatment effects even when given early before the infection sets in.
Around 491 adults across Canada and the US were enrolled in this study. The volunteers had been experiencing the symptoms related to the virus for four days, whereas several volunteers joined in later who just began experiencing the symptoms. This group was only experiencing mild symptoms of the infection and did not need to be hospitalized.
The volunteers were put into groups, with one being given hydroxychloroquine and the other placebo. For the following two weeks, the volunteers were monitored closely to examine if hydroxychloroquine helped improve the symptoms of the virus more than a placebo.
The outcome of the study indicated that hydroxychloroquine was ineffective at treating the symptoms of the virus. It was also noted that Vitamin C and zinc were also ineffective at improving the symptoms.
“The totality of the evidence is there is still no effect,” Boulware said of the pills, which were first approved in the 1950s and are widely used today to treat malaria and lupus.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
